The biopharmaceutical company reported $1.87 EPS for the quarter, beating the Zacks' consensus estimate of $1.78 by $0.09. The stock increased 2.47% or $0.32 during the last trading session, reaching $13.51. Janus Henderson Group PLC now owns 8,408,961 shares of the biopharmaceutical company's stock worth $1,092,071,000 after acquiring an additional 8,217,433 shares during the period. It is down 0.00% since April 16, 2017 and is. It has underperformed by 24.13% the S&P500.
Flossbach Von Storch Ag decreased Cisco Systems (CSCO) stake by 56.53% reported in 2017Q4 SEC filing. The hedge fund run by Sandy Nairn is holding 315,906 shares, compared to the 270,105 from the previous quarter. The institutional investor held 43,694 shares of the consumer services company at the end of 2017Q4, valued at $51.10M, up from 42,043 at the end of the previous reported quarter. The stock increased 0.44% or $0.78 during the last trading session, reaching $175.51. About 563,089 shares traded.
Celgene Corporation (CELG) received negative focus on Friday. CELG underperformed the S&P500 by 42.83%. The insider KAPLAN GILLA sold $1.77 million. On Friday, February 23 the insider Clementi Erich sold $2.01 million. Kaltenbach Patrick sold 4,000 shares worth $269,113.
Investors sentiment increased to 1.29 in 2017 Q4. Its up 0.03, from 0.7 in 2017Q3. It increased, as 54 investors sold IBM shares while 604 reduced holdings.
Aviva PLC raised its stake in Celgene Co. 269.93 million shares or 0.89% more from 267.56 million shares in 2017Q3 were reported. Canal Insur reported 83,000 shares or 4.53% of all its holdings. Kings Point Capital reported 0.01% stake. Everett Harris & Company bought 1,651 shares as the company's stock rose 28.13% while stock markets declined.
Semper Augustus Investments Group Llc holds 2.59% of its portfolio in Mercury General Corporation for 64,761 shares. (NYSE:SPG). Apg Asset Mgmt Nv owns 100,045 shares or 0.03% of their U.S. portfolio. Highbridge Capital Mgmt Lc, New York-based fund reported 122,053 shares. Silchester Invsts Limited Liability Partnership invested in 14,719 shares. Comerica National Bank & Trust, Michigan-based fund reported 453,415 shares. High Pointe Capital Mgmt Limited Company accumulated 225 shares or 0.36% of the stock. Gradient Lc owns 85 shares. 136,085 were accumulated by Boston Family Office Limited Co. Wisconsin-based Mason Street Advisors Ltd Liability Com has invested 1.5% in Amazon.com, Inc. Vigilant Mngmt Ltd invested 0.15% in International Business Machines Corporation (NYSE:IBM). (NASDAQ:DXCM) by 53,950 shares in the quarter, and has cut its stake in Cardinal Health Inc. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twenty-four have assigned a buy rating to the company's stock. Therefore 67% are positive. Amazon.com had 282 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Hold" rating by Stifel Nicolaus given on Tuesday, October 24. The rating was maintained by Imperial Capital on Monday, November 13 with "Hold". (NYSE:FLT) rating on Friday, August 5. Pacific Crest maintained the shares of CSCO in report on Thursday, August 18 with "Overweight" rating. The stock of Celgene Corporation (NASDAQ:CELG) earned "Outperform" rating by BMO Capital Markets on Friday, November 17. Credit Suisse maintained the shares of IBM in report on Tuesday, October 18 with "Underperform" rating. The price target is the price an analyst believes the stock will achieve during their investment time horizon, which for most firms is 12 months. Oppenheimer initiated the shares of IBM in report on Tuesday, August 16 with "Perform" rating. The firm owned 962,318 shares of the biopharmaceutical company's stock after buying an additional 285,542 shares during the quarter.
Since February 8, 2018, it had 1 buying transaction, and 3 insider sales for $3.58 million activity. (NYSE:FLT). Tributary Capital Mngmt Ltd Liability Company accumulated 15,240 shares or 0.26% of the stock. The insider LOUGHLIN JAMES J sold $851,093. Therefore 68% are positive.
According to Zacks, analysts expect that Celgene will report full-year sales of $3.50 billion for the current year, with estimates ranging from $14.60 billion to $15.27 billion. Finally, Cantor Fitzgerald set a $112.00 target price on shares of Celgene and gave the stock a "hold" rating in a research note on Thursday, December 21st. JMP Securities downgraded Celgene Corporation (NASDAQ:CELG) on Friday, October 27 to "Hold" rating. The company rating was maintained by RBC Capital Markets on Tuesday, January 23. Bernstein has "Buy" rating and $40.0 target. On Thursday, December 21 the company was maintained by Guggenheim. The rating was maintained by Credit Suisse on Thursday, July 6 with "Buy". As per Friday, October 23, the company rating was maintained by RBC Capital Markets.
Investors sentiment decreased to 1.2 in Q4 2017. It Payout Ratio is 0.00%. Funds hold 561.38 million shares thus 7.06% less from 2017Q3's 603.99 million shares. First Fincl In reported 463 shares or 0.03% of all its holdings. (NYSE:FLT). Oakbrook Llc reported 0.04% of its portfolio in FleetCor Technologies, Inc. Mcf Advsrs Ltd Liability Company has invested 0% of its portfolio in Celgene Corporation (NASDAQ:CELG). Winslow Evans & Crocker Incorporated owns 11,780 shares.
Celgene (NASDAQ:CELG) last released its earnings results on Thursday, January 25th.
A number of analysts have issued reports on CELG shares. City invested 0.06% of its portfolio in Celgene Corporation (NASDAQ:CELG). Texan Cap Management holds 7,685 shares. Northrock Ptnrs Limited Liability Co reported 8,410 shares. North Carolina-based Jolley Asset has invested 0.04% in Celgene Corporation (NASDAQ:CELG). Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) rating on Friday, October 27. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mngmt Corporation invested in 1.63M shares or 0.25% of the stock. Brave Asset stated it has 39,416 shares or 2.14% of all its holdings. Nomura Inc stated it has 0.02% in Celgene Corporation (NASDAQ:CELG). Finally, Clearbridge Investments LLC raised its stake in Celgene by 17.0% during the fourth quarter.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.